FDA greenlights AI software that detects fractures and traumatic injuries
[ad_1]
New artificial intelligence (AI) software that helps providers diagnose fractures and traumatic injuries on radiographs has been given the green light by the U.S. Food and Drug Administration (FDA).
Gleamer, a French company that specializes in the development of AI software in the radiology space, announced the FDA clearance of its BoneView AI software in a press release earlier this week.
“In the value-based U.S. health care system, providers tell us they want to improve the radiographic diagnostic process, which accounts for a huge part of their workload, and optimize patient…
[ad_2]
Go to publisher site for the complete article:
Read More